substance p has been researched along with Atrial Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dulger, H; Erbilen, E; Guler, N; Gumrukcuoglu, HA; Kutay, V; Ozkara, C; Sahin, M | 1 |
| Cannon, D; Kirrane, J; Legge, D; Powell, D; Skrabanek, P | 1 |
2 other study(ies) available for substance p and Atrial Fibrillation
| Article | Year |
|---|---|
Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery?
Topics: Adrenergic beta-Antagonists; Aging; Angiotensin II; Atrial Fibrillation; Coronary Artery Bypass; Diabetes Complications; Echocardiography; Female; Humans; Male; Middle Aged; Mitral Valve; Myocardium; Neuropeptide Y; Postoperative Period; Prospective Studies; Sodium; Stroke Volume; Substance P | 2007 |
Circulating immunoreactive substance P in man.
Topics: Adult; Aged; Atrial Fibrillation; Colitis, Ulcerative; Female; Humans; Hypertension; Kidney Failure, Chronic; Liver Neoplasms; Male; Radioimmunoassay; Substance P | 1976 |